Panacea biotec is one of the leading biotechnology companies in India. It is the third largest biotechnology companies in terms of revenue and second largest vaccines producer in India. The company is big supplier for polio vaccines to the government of India. It also qualified supplier for vaccines to the WHO for Easy four and couple of other vaccines. The company also has strong pipeline for vaccinies such as Anthrax vaccine. The company has 5 R&D centers and have a few world wide product patents. The companies revenues are highly dependent of polio vaccinies. The company is looking into ways to mitigate this risk and also the risk of foreign currency fluctuations. The company does not have a strong presence in the international markets and looking to ways of strengthening it, one of the options the company is pursuing is acquition of a foreign company.
Some of the recommendations
Emkay
CMP Rs 414 Target Rs 536 12 months January 07 2008
Emkay
CMP Rs 385 Target Rs 536 12 months July 26 2007
Asit C Mehta
CMP Rs 458 Target Rs 554 12 months June 18 2007
Kotak
CMP Rs 425 Target Rs 512 12 months June 15 2007
Quantam Information
CMP Rs 478 Target Rs 675 12 months February 21 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment